ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

233
Analysis
Health Care • Japan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
bullish•Quantitative Analysis
•15 Dec 2019 13:59

🇯🇵 JAPAN • December Sector & Peer Group Relative Price Scores - From Defensives to Cylicals

• RELATIVE PRICE SCORE •RELATIVE PRICE SCORE OUTLIERS - The Relative Price Score (RPS) is a measure of price performance relative to TOPIX...

Logo
339 Views
Share
bullish•Quantitative Analysis
•29 Oct 2019 16:46

Japan - Shorts Cover as Market Rallies

The short notional in the market for the week ended 25 October is US$26.82bn (down by US$0.91bn) with the largest short positions in Itochu Corp...

Logo
396 Views
Share
bullish•Nomura ETF Topix
•25 Sep 2019 06:24

Sep Div Date in Japan - Still Interesting, Still Significant

I often label these insights "Tuesday and Wednesday" because it has often been a Tuesday and Wednesday. This autumn's version is called "Thursday...

Logo
540 Views
Share
•30 Aug 2019 02:17

JPX Nikkei 400 Rebalance - 2019 Edition Done

The JPX Nikkei 400 Rebalances are, from announcement to end, rarely an interesting event. I was not bullish the Adds vs Deletes performance this...

Logo
528 Views
Share
bearish•Quantitative Analysis
•17 Jul 2019 19:08

Short Selling Is Big in Japan

The Japan Exchange Group (JPX) publishes a daily report that details the short sell activity by market participants. Investors are required to...

Logo
613 Views
Share
x